StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
533
This month
5
This year
48
Publishing Date
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 11 - 10
3
2022 - 11 - 09
3
2022 - 11 - 08
3
2022 - 10 - 14
3
2022 - 10 - 06
3
2022 - 09 - 29
3
2022 - 09 - 28
4
2022 - 09 - 26
3
2022 - 09 - 21
3
2022 - 09 - 19
6
2022 - 09 - 16
3
2022 - 09 - 14
3
2022 - 09 - 13
3
2022 - 09 - 09
3
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 08 - 02
3
2022 - 07 - 25
4
2022 - 07 - 19
3
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 22
3
2022 - 06 - 17
6
2022 - 06 - 06
3
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 18
3
2022 - 05 - 17
3
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 04 - 25
3
2022 - 04 - 06
3
2022 - 03 - 31
3
2022 - 03 - 30
3
2022 - 03 - 25
6
2022 - 03 - 23
3
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 16
3
2022 - 03 - 14
3
2022 - 03 - 08
3
2022 - 03 - 04
4
2022 - 03 - 01
4
2022 - 02 - 28
3
2021 - 12 - 22
6
2021 - 12 - 20
4
2021 - 12 - 16
3
2021 - 12 - 14
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
Sector
Commercial services
2
Communications
1
Consumer durables
4
Consumer non-durables
6
Consumer services
1
Distribution services
2
Electronic technology
8
Finance
1
Health services
15
Health technology
533
Information
1
Manufacturing
59
Mining, quarrying, and oil and gas extraction
1
N/a
21
Process industries
5
Producer manufacturing
9
Professional, scientific, and technical services
9
Retail trade
2
Technology services
8
Tags
Als
6
Alzheimer's
8
America
26
Application
6
Approval
8
Biocanada
5
Biosimilar
14
Cancer
47
Car-t
7
Cel
5
Chmp
6
Collaboration
5
Device
6
Diabetes
11
Diabetic
6
Diagnostic
6
Diagnostics
9
Disease
39
Drug
60
Earnings
12
Ema
7
Europe
11
Expected
20
Eye
9
Fda
12
Financial results
5
For
45
Global
80
Growing
19
Growth
119
Health
11
Her2-
6
Immunotherapy
9
Kymriah
5
Leukemia
7
Liver
8
Macular
8
Market
260
Molecular
5
Myeloid leukemia
5
N/a
474
Novartis
66
Patent
6
People
10
Pharma
6
Pharmaceuticals
5
Positive
9
Potential
5
Report
93
Research
57
Respiratory
5
Results
20
Sclerosis
7
Study
9
T-cell
7
Therapeutics
48
Therapy
36
Treatment
67
Trial
6
Vaccine
8
Entities
3m company
5
Abbott laboratories
54
Abbvie inc.
102
Acadia pharmaceuticals inc.
3
Adaptimmune therapeutics plc
5
Akorn inc
4
Albemarle corporation
3
Alcon inc.
4
Alkermes plc
4
Alnylam pharmaceuticals, inc.
3
Amgen inc.
84
Antares pharma, inc.
3
Arrival
5
Astellas pharma inc
32
Astrazeneca plc
91
Bausch health companies inc.
37
Baxter international inc.
20
Becton, dickinson and company
11
Beigene, ltd.
6
Biogen inc.
24
Biomarin pharmaceutical inc.
3
Boston scientific corporation
11
Bristol-myers squibb company
44
Cti biopharma corp.
3
Danaher corporation
4
Eli lilly and company
67
Endo international plc
12
General electric company
7
Genmab a/s
6
Gilead sciences, inc.
17
Glaxosmithkline plc
150
Grifols sa
4
Incyte corporation
9
Jazz pharmaceuticals plc
6
Johnson & johnson
105
Koninklijke philips n.v.
9
Laboratory corporation of america holdings
4
Mallinckrodt plc
7
Medtronic plc
20
Morphosys ag
5
Mylan n.v.
19
Nikon corp
4
Novartis ag
533
Novo nordisk a/s
15
Perrigo company
4
Pfizer, inc.
38
Qiagen n.v.
4
Regeneron pharmaceuticals, inc.
6
Regenxbio inc.
7
Sanofi
140
Smith & nephew plc
6
Stryker corporation
7
Takeda pharmaceutical company limited
29
Taro pharmaceutical industries ltd.
4
Teva pharmaceutical industries limited
5
Teva pharmaceutical industries ltd
106
Thermo fisher scientific inc
25
Uniqure n.v.
5
Viatris inc.
49
Xencor, inc.
5
Symbols
AAPL
700
ABB
888
ABBV
645
ABLZF
629
ABT
1031
AMGN
481
ARVL
2446
AZN
414
BDX
562
BMY
448
BNPQF
993
BNPQY
993
BNPZY
992
BSX
406
CNY
988
CSCO
604
DHR
490
ERIC
1032
EXPR
436
EXTR
482
FNCTF
3506
GE
652
GLAXF
404
GOOG
535
GOOGL
535
GSK
603
HON
1095
HUBS
1010
IBM
425
INR
991
INTC
633
JNJ
2906
LLY
1131
LTUM
533
LYV
471
MDT
881
MLPY
989
MMM
641
MS
2614
MS-PE
417
MSFT
853
NOK
485
NOKBF
469
NVO
402
NVS
736
NVSEF
533
ORCL
786
PFE
507
PHG
620
PPRUF
601
PPRUY
602
SAP
960
SAPGF
695
SNOW
527
SNY
2675
SNYNF
1730
TMO
941
TOT
1012
URR
987
VZ
641
Exchanges
Amex
5
Nasdaq
533
Nyse
533
Crawled Date
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 12 - 15
4
2022 - 12 - 05
3
2022 - 11 - 22
3
2022 - 11 - 10
3
2022 - 11 - 09
3
2022 - 11 - 08
3
2022 - 10 - 14
3
2022 - 10 - 06
3
2022 - 09 - 28
4
2022 - 09 - 26
3
2022 - 09 - 21
3
2022 - 09 - 19
6
2022 - 09 - 16
3
2022 - 09 - 14
3
2022 - 09 - 13
4
2022 - 09 - 09
3
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 08 - 02
3
2022 - 07 - 25
4
2022 - 07 - 19
3
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 06 - 06
3
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 18
3
2022 - 05 - 17
3
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 04 - 25
3
2022 - 04 - 06
3
2022 - 03 - 31
3
2022 - 03 - 30
3
2022 - 03 - 25
6
2022 - 03 - 23
3
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 16
3
2022 - 03 - 14
4
2022 - 03 - 08
3
2022 - 03 - 04
4
2022 - 03 - 01
3
2022 - 02 - 28
3
2021 - 12 - 22
5
2021 - 12 - 20
4
2021 - 12 - 16
3
2021 - 12 - 14
3
2021 - 11 - 12
3
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 28
4
2021 - 10 - 21
3
2021 - 10 - 20
4
2021 - 10 - 13
3
2021 - 10 - 08
3
2021 - 10 - 01
3
Crawled Time
00:00
15
00:20
3
01:00
11
02:00
6
03:00
14
04:00
8
04:20
3
05:00
5
06:00
25
07:00
20
08:00
12
08:20
2
09:00
21
10:00
13
11:00
26
12:00
48
12:20
10
12:30
8
13:00
19
13:15
2
13:20
5
13:30
4
14:00
20
14:15
1
14:20
6
14:30
2
15:00
24
15:15
1
15:20
9
15:30
4
16:00
32
16:20
3
17:00
30
18:00
26
19:00
28
20:00
22
20:20
1
21:00
21
22:00
13
23:00
10
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
1
www.biospace.com
59
www.globenewswire.com
76
www.perion.com
1
www.prnewswire.com
394
www.voyagertherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Nvsef
save search
Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®
Published:
2023-02-03
(Crawled : 00:20)
- globenewswire.com
NVSEF
|
$86.075
0
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
Email alert
Add to watchlist
cosentyx
novartis
year
one
High Adoption Rate Of A New Treatment Against Cancer is likely to proliferate the Neuroendocrine Tumor Treatment CAGR: 10%|UnivDatos Market Insights
Published:
2023-02-03
(Crawled : 15:00)
- prnewswire.com
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-0.05%
|
O:
-0.05%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$145.2
0.25%
0.0%
6.5M
|
Health Technology
|
1.05%
|
O:
1.05%
H:
0.0%
C:
0.0%
treatment
tumor
cancer
market
The Global Antiviral Drugs Market to Exhibit Growth at a Paltry CAGR of ~4% by 2027 | DelveInsight
Published:
2023-02-02
(Crawled : 16:00)
- prnewswire.com
VTRS
|
$12.17
-0.16%
-0.16%
7.1M
|
Health Technology
|
-0.57%
|
O:
-0.16%
H:
0.08%
C:
-0.41%
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-2.46%
|
O:
-1.87%
H:
0.01%
C:
-0.55%
JNJ
|
News
|
$164.61
-0.56%
-0.01%
6.8M
|
Health Technology
|
1.78%
|
O:
0.08%
H:
0.0%
C:
0.0%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.03%
|
O:
-2.99%
H:
3.64%
C:
3.48%
ABBV
|
News
|
$145.2
0.25%
0.0%
6.5M
|
Health Technology
|
-0.16%
|
O:
-0.46%
H:
0.0%
C:
-0.75%
VIR
S
|
$30.14
0.77%
0.76%
860K
|
Health Technology
|
2.57%
|
O:
0.62%
H:
2.22%
C:
1.94%
TNXP
|
$1.24
5.09%
4.84%
2.2M
|
Health Technology
|
5.08%
|
O:
-1.69%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-5.4%
|
O:
-1.44%
H:
0.0%
C:
0.0%
GILD
|
$84.51
3.83%
3.69%
13M
|
Health Technology
|
0.6%
|
O:
-1.95%
H:
0.16%
C:
-1.18%
global
antiviral
growth
market
Bipolar Disorder Market is expected to generate a revenue of USD 6.27 Billion by 2030, Globally, at 2% CAGR: Verified Market Research®
Published:
2023-02-02
(Crawled : 16:00)
- prnewswire.com
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-2.46%
|
O:
-1.87%
H:
0.01%
C:
-0.55%
ABBV
|
News
|
$145.2
0.25%
0.0%
6.5M
|
Health Technology
|
-0.16%
|
O:
-0.46%
H:
0.0%
C:
-0.75%
research
expected
market
Worldwide Pharmaceuticals & Medicine Manufacturing Market: Featuring Johnson & Johnson, Pfizer and Novartis
Published:
2023-02-01
(Crawled : 21:00)
- prnewswire.com
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-2.46%
|
O:
-1.87%
H:
0.01%
C:
-0.55%
JNJ
|
News
|
$164.61
-0.56%
-0.01%
6.8M
|
Health Technology
|
1.78%
|
O:
0.08%
H:
0.0%
C:
0.0%
pharmaceuticals
novartis
Global Precision Medicine Market Competitive Landscape and Trends - By The Business Research Company
Published:
2023-01-31
(Crawled : 13:00)
- prnewswire.com
TMO
|
News
|
$587.76
0.12%
0.0%
1.3M
|
Health Technology
|
2.51%
|
O:
-1.22%
H:
0.0%
C:
0.0%
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-4.57%
|
O:
-0.69%
H:
1.19%
C:
1.18%
MDT
|
News
F
|
$87.1
-0.55%
-0.34%
4.9M
|
Health Technology
|
5.07%
|
O:
0.11%
H:
1.16%
C:
1.14%
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-6.21%
|
O:
-0.35%
H:
0.0%
C:
0.0%
research
global
trends
market
Interstitial cystitis (IC) drugs market size to increase by USD 369.58 million: Analysis of major players as well as the key contributor region - Technavio
Published:
2023-01-31
(Crawled : 03:00)
- prnewswire.com
VTRS
|
$12.17
-0.16%
-0.16%
7.1M
|
Health Technology
|
3.04%
|
O:
0.93%
H:
2.14%
C:
1.84%
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-4.57%
|
O:
-0.69%
H:
1.19%
C:
1.18%
market
Sandoz receives positive CHMP opinion for citrate-free high concentration formulation of adalimumab biosimilar
Published:
2023-01-30
(Crawled : 07:00)
- globenewswire.com
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-3.75%
|
O:
0.86%
H:
0.0%
C:
0.0%
biosimilar
for
chmp
positive
Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market
Published:
2023-01-27
(Crawled : 13:00)
- biospace.com/
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-5.45%
|
O:
-1.77%
H:
0.0%
C:
0.0%
market
Lipid Based Formulations Global Market Report 2023: Featuring Novartis, AbbVie, F. Hoffmann-La Roche, Johnson & Johnson, Alnylam Pharmaceuticals & More
Published:
2023-01-27
(Crawled : 12:20)
- prnewswire.com
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-5.45%
|
O:
-1.77%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$164.61
-0.56%
-0.01%
6.8M
|
Health Technology
|
-2.09%
|
O:
-0.5%
H:
0.0%
C:
0.0%
pharmaceuticals
global
report
market
Global Infertility Drugs Market Report 2022: Sector to Reach $4.8 Billion by 2028 at a 6.2% CAGR
Published:
2023-01-26
(Crawled : 00:00)
- prnewswire.com
PFE
2 d
|
$44.06
-0.63%
-0.02%
24M
|
Health Technology
|
0.34%
|
O:
-0.05%
H:
0.0%
C:
0.0%
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-5.45%
|
O:
-1.77%
H:
0.0%
C:
0.0%
ABT
|
News
|
$111.79
-0.41%
0.0%
3.8M
|
Health Technology
|
0.45%
|
O:
-0.74%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-6.5%
|
O:
-1.25%
H:
0.0%
C:
0.0%
global
report
market
Intravitreal Injectables Global Market Report 2022: Featuring Allergan, Bristol-Myers Squibb, Novartis, F.Hoffman-La Roche & More
Published:
2023-01-26
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$86.075
0
|
Health Technology
|
-3.77%
|
O:
-1.1%
H:
0.0%
C:
0.0%
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-6.64%
|
O:
-1.25%
H:
0.0%
C:
0.0%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
0.89%
|
O:
0.7%
H:
0.0%
C:
0.0%
REGN
|
$782.76
4.2%
4.03%
1.4M
|
Health Technology
|
4.96%
|
O:
1.46%
H:
0.0%
C:
0.0%
global
report
roche
market
Worldwide Orthopedic Oncology Treatment Industry to 2030 - Dominating Segment is Reconstructive Surgery
Published:
2023-01-26
(Crawled : 01:00)
- prnewswire.com
SNYNF
|
News
|
$98.55
0
|
Health Technology
|
0.22%
|
O:
-0.49%
H:
0.0%
C:
0.0%
NVSEF
|
$86.075
0
|
Health Technology
|
-3.77%
|
O:
-1.1%
H:
0.0%
C:
0.0%
ZBH
|
$129.45
1.6%
0.0%
2.8M
|
Health Technology
|
2.26%
|
O:
1.12%
H:
0.0%
C:
0.0%
SYK
|
News
|
$283.14
0.23%
0.0%
1.5M
|
Health Technology
|
11.48%
|
O:
0.78%
H:
0.0%
C:
0.0%
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-6.64%
|
O:
-1.25%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$164.61
-0.56%
-0.01%
6.8M
|
Health Technology
|
-0.83%
|
O:
1.29%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-5.67%
|
O:
0.89%
H:
0.0%
C:
0.0%
treatment
Global Psoriasis Therapeutics Market Report to 2031 - Featuring Abbvie, Amgen, Bausch Health, LEO Pharma and Novan Among Others
Published:
2023-01-25
(Crawled : 21:00)
- prnewswire.com
NVSEF
|
$86.075
0
|
Health Technology
|
-3.77%
|
O:
-1.1%
H:
0.0%
C:
0.0%
VTRS
|
$12.17
-0.16%
-0.16%
7.1M
|
Health Technology
|
5.45%
|
O:
0.0%
H:
0.87%
C:
0.69%
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-6.64%
|
O:
-1.25%
H:
0.0%
C:
0.0%
LLY
M
|
$339.08
2.53%
0.83%
5.7M
|
Health Technology
|
-3.78%
|
O:
1.48%
H:
0.34%
C:
-0.85%
BHC
|
$7.86
-0.51%
0.0%
1.8M
|
Health Technology
|
-4.93%
|
O:
2.77%
H:
3.28%
C:
-0.23%
ABBV
|
News
|
$145.2
0.25%
0.0%
6.5M
|
Health Technology
|
-0.63%
|
O:
0.15%
H:
0.0%
C:
0.0%
AMGN
|
$245.12
-0.57%
-0.58%
3.1M
|
Health Technology
|
-4.53%
|
O:
-1.76%
H:
0.0%
C:
0.0%
leo
pharma
global
report
therapeutics
psoriasis
market
Insights on the Alzheimer's Drugs Global Market to 2027 - Hospital Sector will Capture more Revenue in Upcoming Years
Published:
2023-01-25
(Crawled : 21:00)
- prnewswire.com
SNYNF
|
News
|
$98.55
0
|
Health Technology
|
0.22%
|
O:
-0.49%
H:
0.0%
C:
0.0%
NVSEF
|
$86.075
0
|
Health Technology
|
-3.77%
|
O:
-1.1%
H:
0.0%
C:
0.0%
PFE
2 d
|
$44.06
-0.63%
-0.02%
24M
|
Health Technology
|
-1.53%
|
O:
-1.87%
H:
0.0%
C:
0.0%
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-6.64%
|
O:
-1.25%
H:
0.0%
C:
0.0%
GSK
|
$34.83
-0.85%
0.03%
3.6M
|
Health Technology
|
1.03%
|
O:
0.89%
H:
0.0%
C:
0.0%
LLY
M
|
$339.08
2.53%
0.83%
5.7M
|
Health Technology
|
-3.78%
|
O:
1.48%
H:
0.34%
C:
-0.85%
ABT
|
News
|
$111.79
-0.41%
0.0%
3.8M
|
Health Technology
|
1.71%
|
O:
1.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-5.67%
|
O:
0.89%
H:
0.0%
C:
0.0%
global
alzheimer's
market
Ophthalmology therapeutics market size to increase by USD 15.72 billion: North America will account for 44% of market growth - Technavio
Published:
2023-01-24
(Crawled : 19:00)
- prnewswire.com
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-6.48%
|
O:
0.17%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$145.2
0.25%
0.0%
6.5M
|
Health Technology
|
-0.9%
|
O:
-0.27%
H:
0.0%
C:
0.0%
america
for
therapeutics
growth
market
Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio
Published:
2023-01-23
(Crawled : 00:00)
- globenewswire.com
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-6.27%
|
O:
-0.14%
H:
0.48%
C:
0.36%
mycamine
offering
acquire
antifungal
agreement
Allergy immunotherapies market: Driving factors, industry challenges, segmentation, key vendor analysis, leading countries, and market size and forecast 2023-2027 - Technavio
Published:
2023-01-23
(Crawled : 19:00)
- prnewswire.com
VTRS
|
$12.17
-0.16%
-0.16%
7.1M
|
Health Technology
|
3.13%
|
O:
-0.51%
H:
0.26%
C:
-1.36%
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-6.27%
|
O:
-0.14%
H:
0.48%
C:
0.36%
market
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
Published:
2023-01-23
(Crawled : 17:00)
- biospace.com/
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-6.42%
|
O:
-0.15%
H:
0.0%
C:
0.0%
Addiction Disorders Drugs Market Report 2022: Sector to Reach $32.65 Billion by 2027 at a CAGR of 6.35%
Published:
2023-01-21
(Crawled : 16:20)
- prnewswire.com
GLAXF
|
$17.28
0
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
Email alert
Add to watchlist
PMD
|
$5.62
0.53%
2.7K
|
Health Services
|
Email alert
Add to watchlist
NVSEF
|
$86.075
0
|
Health Technology
|
Email alert
Add to watchlist
PRGO
|
$37.2
0.41%
0.0%
1M
|
Health Technology
|
Email alert
Add to watchlist
ALKS
|
$27.36
-0.94%
-0.95%
910K
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$34.83
-0.85%
0.03%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
MDT
|
News
F
|
$87.1
-0.55%
-0.34%
4.9M
|
Health Technology
|
Email alert
Add to watchlist
report
market
← Previous
1
2
3
4
5
6
7
8
9
…
26
27
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.